IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
By Markus F. Neurath, S. Finotto. Cytokine & growth factor reviews, 2011
601 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/9ef0857f3769790f90365a6d7a774814e627cf93
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- X. Yao
- N. Shen
- Jiaqi Huang
- M. Fung
- Yihong Yao
- R. Faggioni
- Haihong Zhong
Citations in the corpus
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. (2014, background): “Further studies have shown that IL-6 is a critical regulator of IBD pathogenesis by influencing immune cells (Neurath & Finotto, 2011).”